Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Blood (2011) 118 (17): 4567–4576.
Currently there are no citedby results. Try again later.
